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Antimicrobial peptideWhile high-resolution 3D structures reveal the locations of all atoms in a molecule, it is the dynamics that
correlates the structure with the function of a biological molecule. The complete characterization of
dynamics of a membrane protein is in general complex. In this study, we report the inﬂuence of dynamics on
the channel-forming function of pardaxin using chemical shifts and dipolar couplings measured from 2D
broadband-PISEMA experiments on mechanically aligned phospholipids bilayers. Pardaxin is a 33-residue
antimicrobial peptide originally isolated from the Red Sea Moses sole, Pardachirus marmoratus, which
functions via either a carpet-type or barrel-stave mechanism depending on the membrane composition. Our
results reveal that the presence of cholesterol signiﬁcantly reduces the backbone motion and the tilt angle of
the C-terminal amphipathic helix of pardaxin. In addition, a correlation between the dynamics-induced
heterogeneity in the tilt of the C-terminal helix and the membrane disrupting activity of pardaxin by the
barrel-stave mechanism is established. This correlation is in excellent agreement with the absence of
hemolytic activity for the derivatives of pardaxin. These results explain the role of cholesterol in the
selectivity of the broad-spectrum of antimicrobial activities of pardaxin.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Design of novel antibiotic compounds to overcome the increasing
bacterial resistance towards conventional antibiotics is of consider-
able current importance [1]. Numerous studies have reported the
isolation, characterization, biological functions, and potential phar-
maceutical applications of naturally occurring AMPs [2,3]. A variety of
biochemical and biophysical approaches have reported mechanisms
of membrane permeation/disruption, bioavailability, and synergistic
activities of AMPs [4–7]. High-resolution cutting-edge techniques
have been used to obtain atomic-level insights into the structure,
dynamics, folding, oligomerization, and membrane orientation of
AMPs and their interactions with lipid membrane [8]. These studies
have been utilized in the design of potent peptide antibiotics [9–11].
In spite of these valuable studies, unfortunately, only a very few
peptides have been found to be suitable for pharmaceutical appli-
cations [5,12–15]. One of the major difﬁculties in designing potent
AMPs is determining the role of membrane components that play
important roles in the selectivity of AMPs. Therefore, there is aorthy).
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membrane components on the function of AMPs. In this study, we
report atomic-level insights into the role of cholesterol on the
function of pardaxin using solid-state NMR experiments on mechan-
ically aligned model phospholipid membranes. Cholesterol is abun-
dantly present in mammalian membranes, but not in bacterial
membranes, and has been thought to be crucial in reducing the
toxicity of AMPs.
Pardaxin is a 33-residue antimicrobial peptide originally isolated
from the secretions from the Red Sea Moses sole, Pardachirus
marmoratus. Pardaxin has been shown to exhibit a broad-spectrum
of antimicrobial activities at very low concentrations, to act as a
channel-forming neurotoxin, and also to cause cell death by necrosis
at slightly higher concentrations [16–21]. Amino acid sequences of
pardaxin peptides are given in Fig. 1 along with the 3D NMR structure
of the peptide. An early NMR study on pardaxin in a TFE:water
solution reported a helix–hinge–helix structure similar to that of
melittin [22]. But a recent NMR study reported the more biologically
relevant structure of the peptide in a membrane environment, where
the structure of the N-terminal domain signiﬁcantly differs from that
obtained from TFE:water structure (Fig. 1) [23]. Recent NMR studies
have also reported the membrane orientation, role of membrane
composition, and potential mechanisms of the membrane permeation
of pardaxin [23,24]. The antimicrobial activities of peptide fragments
corresponding to 1–11, 1–18, 1–22, 10–33, and 12–33 residues of
pardaxin and several mutants have also been reported. The amidated
forms of the 22-residues C-terminal fragment and the 11 amino acid
Fig. 1. Pardaxin—a cationic antimicrobial peptide originally isolated from the Red Sea
Moses sole, Pardachirus marmoratus. (A) Amino acid sequences of pardaxin peptides.
Pa4 was used in this study. (B) NMR structure of pardaxin determined from DPC
micelles [23]. (C) A helical wheel representation of the C-terminal amphipathic domain
of pardaxin.
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positive bacteria 17], whereas the fragment 1–18 has been shown to
be active against Escherichia coli but not against Gram-positive
bacteria [25]. These differences in the activities of the derivatives of
pardaxin are not well understood.
In this study, we show that the presence of cholesterol reduces the
dynamics of pardaxin but does not inﬂuence the membrane
orientation of pardaxin. Inﬂuences of temperature and cholesterol
on the backbone dynamics of pardaxin are investigated using a
combination of 2D broadband-PISEMA (polarization inversion spin
exchange at the magic angle) experiments and mechanically aligned
phospholipids bilayers to accurately measure 15N chemical shifts and
1H–15N dipolar couplings [26–28]. Implications of solid-state NMR
results on the mechanisms of membrane disruption and selectivity by
pardaxin are discussed.2. Materials and methods
2.1. Materials
Methanol and chloroform were purchased from Aldrich Chemical
Inc. (Milwaukee, WI). Phospholipids, cholesterol, and naphthalene
were purchased from Avanti Polar Lipids (Alabaster, AL), Sigma (St.
Louis, MO), and Fisher Scientiﬁc (Pittsburg, PA), respectively. All
these chemicals were used without further puriﬁcation. All peptides
were synthesized and puriﬁed as explained in our earlier publication
[24]. Mechanically aligned bilayer samples were prepared using the
naphthalene procedure as explained in our previous publications
[29].
2.2. Solid-state NMR
All of the solid-state NMR experiments were performed on a
Chemagnetics/Varian Inﬁnity 400 MHz spectrometer operating at
resonance frequencies of 400.138, 161.979, and 40.55 MHz for 1H, 31P,
and 15N nuclei, respectively using home-built ﬂat-coil probes. 31P
chemical shift spectra obtained using a spin-echo sequence (90°–τ–
180°–τ-acquisition; τ=70 μs) with a 90° pulse length of 3.5 μs under
40 kHz proton decoupling were used to conﬁrm the alignment of each
mechanically aligned bilayer samples after an equilibration for about
30 min at a chosen temperature before recording the spectrum. All
reported solid-state NMR experiments were performed with the
bilayer normal of the sample oriented parallel to the external
magnetic ﬁeld. After optimization of the experimental conditions for
sensitivity, resolution, and sample stability using a series of 1D NMR
experiments as explained elsewhere [28], 2D BB-PISEMA experiments
were performed as explained in our previous publication [26]. A ramp
cross-polarization sequence with a 1H π/2 pulse length of 3 μs, 50 kHz
cross-polarization power, a 1H decoupling of 75 kHz during acqui-
sition, and a 2 s recycle delay were used in 1D experiments. An RF ﬁeld
strength of 62.5 kHz was used for the Lee–Goldburg off-resonance
pulses during the t1 period of BB-PISEMA. 32 t1 increments each with
3600 scans were recorded for 2D BB-PISEMA spectra. All experimental
data were processed using the Spinsight (Chemagnetics/Varian)
software on a Sun SPARC workstation.
3. Results
A previous solid-state NMR study reported a transmembrane
orientation for the C-terminal helix of pardaxin in DMPC and a
membrane surface orientation in POPC bilayers [24]. Since we are
interested in probing the role of cholesterol on the dynamics of the
peptide and its implications for the barrel-stave mechanism of
membrane disruption by pardaxin, we chose to use DMPC and
DMPG lipids for this study in which the peptide is in a transmembrane
orientation. Two types of model membrane compositions were used
in this study: 3:1 DMPC:DMPG bilayers and DMPC bilayers containing
15 mol% cholesterol to understand the role of cholesterol present in
mammalian membranes. 2D BB-PISEMA spectra of these samples at
various temperatures are given in Fig. 2. A single peak observed in the
15N chemical shift region of 175 to 183 ppm and a 15N–1H dipolar
coupling frequency of 8–9.3 kHz conﬁrms the transmembrane
orientation of the C-terminal helix of pardaxin under this condition.
2D experiments were performed to measure the inﬂuence of
temperature in the presence and absence of cholesterol. A decrease
in both the 15N chemical shift and 15N–1H dipolar coupling
frequencies were observed with increasing temperature in the
absence of cholesterol (Fig. 3A). On the other hand, no signiﬁcant
changes were observed in the presence of cholesterol (Fig. 3B). A
model explaining the inﬂuence of cholesterol on lipid bilayers and on
pardaxin's backbone dynamics is depicted in Fig. 4 and discussed
below.
Fig. 2. The C-terminal helical segment of pardaxin has a transmembrane orientation. 2D BB-PISEMA spectra of mechanically aligned lipid bilayers containing 2 mol% 15N-Ala21-
pardaxin: (top) 3:1 DMPC:DMPG bilayers and (bottom) DMPC bilayers with 15 mol% cholesterol at 30, 37 and 43 °C. A single peak observed in each spectrum, even in the absence of
cholesterol, suggests an average of dynamically disordered tilts of the C-terminal helical domain of pardaxin.
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Previous solid-state NMR studies have shown that pardaxin has a
transmembrane orientation in DMPC bilayerswhile it is oriented close
to the bilayer surface of POPC bilayers due to the hydrophobic
mismatch between its hydrophobic length and the hydrophobic
thickness of the lipid bilayer [23,24]. In this study we measured the
backbone dynamics of the C-terminal amphipathic helix of pardaxin
using solid-state NMR experiments on mechanically aligned lipid
bilayers at various temperatures. Dipolar couplings between 15N and
1H nuclei at the amide site of pardaxin selectively labeled with 15N
isotope were accurately measured using 2D broadband-PISEMA
experiments. The inﬂuence of cholesterol embedded in lipid bilayers
on the dynamics of pardaxin was also investigated.
4.1. PISEMA experiments on mechanically aligned lipid bilayers provide
piercing insights into pardaxin's function
A number of studies have well utilized a combination of PISEMA
and mechanically aligned lipid bilayers to investigate folding and
topology of membrane-associated peptides and proteins [30–36]. This
approach has also revealed mechanisms of membrane disruption by
antimicrobial peptides [37–40] and amyloid peptides [41]; and in factFig. 3. Cholesterol reduces pardaxin's dynamics in lipid bilayers. Changes in 15N
chemical shift (A) and 1H–15N dipolar coupling (B) frequencies measured from 2D
BB-PISEMA spectra of 3:1 DMPC:DMPG bilayers (open circles) and DMPC bilayers with
15 mol% cholesterol (ﬁlled triangles).the geometry of toroidal pores induced by antimicrobial peptides was
also determined at high resolution [42,43]. Previous studies have
shown that the absence of the overall motion is an advantage in the
structural studies of transmembrane proteins [30]. Lack of bulk water
in mechanically aligned bilayers enabled the measurement of
backbone dynamics only frommembrane-bound peptide populations.
Therefore, in this study, we used this approach to determine the
inﬂuence of the backbone dynamics on the function of pardaxin.
Pardaxin was labeled with 15N at the amide site of Ala21 residue,
which is located in the helical region of the peptide (Fig. 1B) [23]. A
single peak observed near the parallel edge of 15N chemical shift
anisotropy with an N-H dipolar coupling ∼8 kHz in 2D PISEMA (Fig. 2)
spectra suggest that the C-terminal helix has a transmembrane
orientation conﬁrming previously reported channel-forming mecha-
nism of Pardaxin [23,24]. The variation of NMR parameters with
temperature is given in Fig. 3 and discussed below.
4.2. Cholesterol reduces pardaxin's dynamics and disorder in its
transmembrane orientation
Our previous solid-state NMR study could not differentiate the
effects of the tilt of the C-terminal amphipathic helix from the bilayer
normal and the peptide's dynamics on the observed 15N chemical shift
frequency from mechanically aligned bilayers [24]. In this study, we
measured 15N chemical shift and 1H–15N dipolar coupling values by
varying the temperature. As seen from 2D PISEMA data in Fig. 2, both
chemical shift and dipolar coupling values decrease as the temper-
ature of the sample is increased. These results suggest that the
transmembrane orientation of the peptide is disordered due to
dynamics. Increasing temperature increases the mobility of the
transmembrane C-terminal helix rendering the peptide to orient
heterogeneously relative to the bilayer normal. On the other hand, a
decreasing temperature reduces the mobility of the helix and also the
disorder in the tilt of the helix. Our results in Figs. 2 and 3 indicate that
the presence of cholesterol decreases the disorder in the tilt of the C-
terminal helix and also its mobility even at 43 °C. This is mainly
because cholesterol increases the order of acyl chains of the lipid
bilayer, which restricts the mobility of the C-terminal helix of the
peptide (Fig. 4). These observed changes in the mobility of the
Fig. 4. A model depicting the dynamics-driven membrane orientation of pardaxin. (A) Disordered lipid acyl chains thin the bilayer and therefore disordered tilted orientations are
expected for the C-terminal helix of pardaxin. (B) The presence of cholesterol thickens the lipid bilayer, reduces the dynamical disorder in the transmembrane region, and could
reduce the channel activity and hemolytic activity of pardaxin.
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due to the presence of cholesterol or because of a change in the
temperature suggest that peptide-peptide interactions are not
sufﬁciently strong to retain the same tilt angle of the helix. This is in
excellent agreement with the previously reported difference in the
membrane orientation of the C-terminal helix in DMPC vs. POPC
bilayers due to hydrophobicmismatch [23,24]. These results therefore
imply that cholesterol signiﬁcantly inﬂuences the barrel-stave
mechanism of pardaxin; similar effects have been reported for other
channel-forming peptides like melittin [24,44–50]. Since cholesterol
is abundantly present in mammalian cell membranes, it would be
interesting to investigate the effect of higher concentration of
cholesterol on the barrel-stave activities of pardaxin. A higher
concentration of cholesterol could prevent the membrane insertion
of pardaxin [16]. It is also be possible that the direct interaction
between cholesterol and pardaxin could play some role in the
observed dynamical changes or tilt of the helix, particularly at a
concentration of cholesterol higher than used in this study. More
solid-state NMR experimental measurements are needed to conﬁrm
this effect. Such studies will be useful in understanding the role of
cholesterol on channel-forming peptides and proteins in general, and
possibly on the fusiogenic activities of viral proteins [51,52].
Cholesterol is also known to play important roles in the membrane
toxicity of channel-forming amyloid peptides [53–57].
4.3. Cholesterol effectively suppresses carpet-type and barrel-stave
mechanisms of pardaxin
Solid-state NMR experiments on mechanically aligned POPC and
POPC:POPG bilayers revealed the membrane surface orientation of
pardaxin and peptide-induced disorder near the lipid head group
region and in the hydrophobic core of the bilayer [23,24]. These
studies also reported that pardaxin disrupts membrane via a carpet-
type mechanism which was found to be inhibited by the presence of
cholesterol. Since cholesterol decreases lipid acyl chain disorder in
the hydrophobic region of bilayers, it readily suppresses membrane
disruption by those AMPs that functioning via a carpet-type
mechanism [37,58,59]. As a consequence the concentration of an
AMP required to disrupt a mammalian cell membrane is higher than
MIC. This also explains the presence of unperturbed cholesterol-rich
domains in lipid bilayers even at a concentration as high as 5 mol%
pardaxin as reported from our previous solid-state NMR and DSC
studies [24,60]. The decrease in the backbone dynamics is expected tosuppress the channel-forming activity of pardaxin and therefore
would play a role in the selectivity of this antimicrobial peptide. This
prediction from our studies enables us to hypothesize that any
mutation of pardaxin that is accompanied by a reduction in the
dynamical disorder of the C-terminal helix would reduce the
hemolytic activity of the mutant peptide. For example, a substitution
of Ala for Pro-13 should extend the helicity towards the N-terminal
domain by removing the hinge and therefore should signiﬁcantly
suppress the dynamical disorder in the C-terminal transmembrane
helical region of themutant. Such Pro to Alamutation has indeed been
reported to abolish the toxicity of the peptide [7]. It is also interesting
to note that similar behavior has been reported for a derivative of
pardaxin that lacks the ﬁrst 9 N-terminal residues [7]. Since this
derivative lacks the N-terminal domain and the disorder in its
membrane orientation could be smaller, its hemolytic as well as
antimicrobial activities are considerably reduced. Therefore, there is a
clear correlation between the dynamics-induced heterogeneity in the
tilt of the C-terminal helix and the barrel-stave mechanism of
pardaxin. Therefore, we believe these ﬁnding will be useful in the
design of potent and highly selective peptides.
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